MacroGenics
MGNX
#8705
Rank
NZ$0.45 B
Marketcap
NZ$7.13
Share price
0.99%
Change (1 day)
187.99%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: NZ$0.45 Billion

As of September 2026 MacroGenics has a market cap of NZ$0.45 Billion. This makes MacroGenics the world's 8705th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.45 B158.41%
2025NZ$0.17 B-51.08%
2024NZ$0.35 B-61.9%
2023NZ$0.94 B45.23%
2022NZ$0.64 B-54.9%
2021NZ$1.44 B-19.16%
2020NZ$1.78 B

End of Day market cap according to different sources

On Sep 16th, 2026 the market cap of MacroGenics was reported to be:

NZ$0.45 Billion
by Nasdaq info icon info icon
NZ$0.45 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$273.66 B 60,121.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.774 T 390,301.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$355.76 B 78,187.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$320.17 B 70,357.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$625.11 B 137,461.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$227.15 B 49,887.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$3.08 B 578.32%๐Ÿ‡บ๐Ÿ‡ธ USA